We focus identification of the genetic lesions underlying cancer pathogenesis and gene-targeted therapies tailored to individual cancer patients. Learn more.
Our research can be characterized by two primary interests:
- Identify the genetic lesions underlying cancer pathogenesis for each cancer patient.
- Identify specific, gene-targeted therapies that can be individually tailored to cancer patients on the basis of their causative oncogenic lesions.